Market Value7,560,766,669
Total Holdings78
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TSHA / Taysha Gene Therapies, Inc.
CMRX / Chimerix, Inc.
INBX.V / Inhibrx, Inc.
LRMR / Larimar Therapeutics, Inc.
HOWL / Werewolf Therapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
MGX / Metagenomi Therapeutics, Inc.
ACET / Adicet Bio, Inc.
URGN / UroGen Pharma Ltd.
PCSC / Perceptive Capital Solutions Corp
SERA / Sera Prognostics, Inc.
GHRS / GH Research PLC
PRAX / Praxis Precision Medicines, Inc.
MGNX / MacroGenics, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
ABOS / Acumen Pharmaceuticals, Inc.
ACRV / Acrivon Therapeutics, Inc.
PEPG / PepGen Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
AXSM / Axsome Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
VXRT / Vaxart, Inc.
ELYM / Eliem Therapeutics, Inc.
INSM / Insmed Incorporated
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
PCVX / Vaxcyte, Inc.
CRVO / CervoMed Inc.
ATXS / Astria Therapeutics, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
EVH / Evolent Health, Inc.
FULC / Fulcrum Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
BIIB / Biogen Inc.
DYN / Dyne Therapeutics, Inc.
SCLX / Scilex Holding Company
THRD / Third Harmonic Bio, Inc.
CGON / CG Oncology, Inc.
WVE / Wave Life Sciences Ltd.
NAMS.W / NewAmsterdam Pharma Company N.V. - Equity Warrant
TARA / Protara Therapeutics, Inc.
CTKB / Cytek Biosciences, Inc.
SRZN / Surrozen, Inc.
RGLS / Regulus Therapeutics Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S
CVAC / CureVac N.V.
LENZ / LENZ Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
LBPH / Longboard Pharmaceuticals, Inc.
ELVN / Enliven Therapeutics, Inc.
CYBN / Cybin Inc.
LXEO / Lexeo Therapeutics, Inc.
ZURA / Zura Bio Limited
TNYA / Tenaya Therapeutics, Inc.
APGE / Apogee Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
IMTX / Immatics N.V.
NUVL / Nuvalent, Inc.
ETNB / 89bio, Inc.
NRIX / Nurix Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.
IGMS / IGM Biosciences, Inc.
ANTX / AN2 Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
EWTX / Edgewise Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
BOLD / Boundless Bio, Inc.
SPRY / ARS Pharmaceuticals, Inc.
RXST / RxSight, Inc.
UNCY / Unicycive Therapeutics, Inc.
BDTX / Black Diamond Therapeutics, Inc.
ANRO / Alto Neuroscience, Inc.
ACLX / Arcellx, Inc.
GERN / Geron Corporation
SLDB / Solid Biosciences Inc.
CCCC / C4 Therapeutics, Inc.
NKTX / Nkarta, Inc.
MLYS / Mineralys Therapeutics, Inc.
RXRX / Recursion Pharmaceuticals, Inc.
TRML / Tourmaline Bio, Inc.
ARVN / Arvinas, Inc.
RNA / Atrium Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
VOR / Vor Biopharma Inc.